195 related articles for article (PubMed ID: 22926798)
1. Gastric juice microRNA-421 is a new biomarker for screening gastric cancer.
Zhang X; Cui L; Ye G; Zheng T; Song H; Xia T; Yu X; Xiao B; Le Y; Guo J
Tumour Biol; 2012 Dec; 33(6):2349-55. PubMed ID: 22926798
[TBL] [Abstract][Full Text] [Related]
2. Downregulated MicroRNA-133a in Gastric Juice as a Clinicopathological Biomarker for Gastric Cancer Screening.
Shao J; Fang PH; He B; Guo LL; Shi MY; Zhu Y; Bo P; Zhen-Wen ZW
Asian Pac J Cancer Prev; 2016; 17(5):2719-22. PubMed ID: 27268657
[TBL] [Abstract][Full Text] [Related]
3. Gastric juice miR-129 as a potential biomarker for screening gastric cancer.
Yu X; Luo L; Wu Y; Yu X; Liu Y; Yu X; Zhao X; Zhang X; Cui L; Ye G; Le Y; Guo J
Med Oncol; 2013 Mar; 30(1):365. PubMed ID: 23307240
[TBL] [Abstract][Full Text] [Related]
4. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.
Cui L; Zhang X; Ye G; Zheng T; Song H; Deng H; Xiao B; Xia T; Yu X; Le Y; Guo J
Cancer; 2013 May; 119(9):1618-26. PubMed ID: 23335180
[TBL] [Abstract][Full Text] [Related]
5. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
7. Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer.
Yang Y; Shao Y; Zhu M; Li Q; Yang F; Lu X; Xu C; Xiao B; Sun Y; Guo J
Tumour Biol; 2016 Jan; 37(1):1183-8. PubMed ID: 26280398
[TBL] [Abstract][Full Text] [Related]
8. Gastric juice piR-1245: A promising prognostic biomarker for gastric cancer.
Zhou X; Liu J; Meng A; Zhang L; Wang M; Fan H; Peng W; Lu J
J Clin Lab Anal; 2020 Apr; 34(4):e23131. PubMed ID: 31777102
[TBL] [Abstract][Full Text] [Related]
9. Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human.
Parvaee P; Sarmadian H; Khansarinejad B; Amini M; Mondanizadeh M
Asian Pac J Cancer Prev; 2019 May; 20(5):1421-1426. PubMed ID: 31127902
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
12. Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
Anticancer Res; 2018 Feb; 38(2):613-616. PubMed ID: 29374683
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
Su ZX; Zhao J; Rong ZH; Wu YG; Geng WM; Qin CK
Tumour Biol; 2014 Dec; 35(12):12119-25. PubMed ID: 25416437
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
[TBL] [Abstract][Full Text] [Related]
15. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
16. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
17. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.
Shao Y; Ye M; Li Q; Sun W; Ye G; Zhang X; Yang Y; Xiao B; Guo J
Oncotarget; 2016 Jun; 7(25):37812-37824. PubMed ID: 27192121
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of low miR-144 expression in gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 20(4):547-552. PubMed ID: 28800316
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients.
Zheng Y; Cui L; Sun W; Zhou H; Yuan X; Huo M; Chen J; Lou Y; Guo J
Cancer Biomark; 2011-2012; 10(2):71-7. PubMed ID: 22430134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]